UBS Group
HIMS icon

UBS Group’s Hims & Hers Health HIMS Stock Holding History

UBS Group’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.53M Buy
+170,000
New +$4.02M ﹤0.01% 4430
2025
Q4 		– Sell
-126,000
Closed -$7.15M – 10795
2025
Q3 		$7.15M Sell
126,000
-62,800
-33% -$3.22M ﹤0.01% 3659
2025
Q2 		$9.41M Sell
188,800
-66,600
-26% -$3.01M ﹤0.01% 3143
2025
Q1 		$7.55M Buy
+255,400
New +$9.49M ﹤0.01% 3354

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's HIMS Position: Q1 2026 in Review

UBS Group reduced its Hims & Hers Health (HIMS) stake by 8.7% in Q1 2026, selling an estimated $9.39M and leaving 4,151,638 shares worth $86.2M. The position accounts for 0.01% of the portfolio, ranked #1163.

UBS Group first reported a position in HIMS in Q2 2020 and has held it in 22 quarters since. The position peaked at $162M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • UBS Group held 4,151,638 shares of Hims & Hers Health worth $86.2M as of Q1 2026.
  • UBS Group sold 397,446 Hims & Hers Health shares in Q1 2026, an estimated $9.39M.
  • Hims & Hers Health made up 0.01% of UBS Group's portfolio in Q1 2026, its #1163 holding.
  • UBS Group first reported a position in Hims & Hers Health in Q2 2020 and has held it in 22 quarters since.
  • UBS Group's Hims & Hers Health position peaked at $162M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.